Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by University of Pittsburgh
Hemispherx Biopharma
Information provided by (Responsible Party):
Pawel Kalinski, University of Pittsburgh Identifier:
First received: February 29, 2012
Last updated: December 23, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2017
  Estimated Primary Completion Date: August 2016 (Final data collection date for primary outcome measure)